Solid forms for tissue repair
This invention provides aragonite- and calcite-based scaffolds for the repair, regeneration, enhancement of formation or a combination thereof of cartilage and/or bone, which scaffolds comprise at least two phases, wherein each phase differs in terms of its chemical content, or structure, kits comprising the same, processes for producing solid aragonite or calcite scaffolds and methods of use thereof.
1. A scaffold for tissue repair, said scaffold consisting essentially of two phases wherein:
a first phase of said two phases comprises solid coral and a biocompatible polymer and said first phase further comprises a series of hollows along a longitudinal axis in said first phase, and wherein said polymer penetrates to within said hollows; and
a second phase of said two phases comprises a solid coral
wherein said biocompatible polymer is a glycosaminoglycan, a chitosan, an alginate or a combination thereof.
2. The scaffold of claim 1 , wherein said biocompatible polymer comprises chitosan.
3. The scaffold of claim 2 , wherein said chitosan comprises cross-linked chitosan.
4. The scaffold of claim 1 , wherein said biocompatible polymer comprises an alginate.
5. The scaffold of claim 1 , wherein said scaffold further comprises a cytokine, a chelator, a cell population, an anti-inflammatory compound, an anti-infective compound, a growth factor, an antibiotic, a pro-angiogenic factor, a therapeutic compound, or any combination thereof.
6. The scaffold of claim 5 , wherein said cell population comprises mesenchymal stem cells, osteoblasts, osteocytes, osteoclasts, chondroblasts, chondrocytes, fibroblasts, or a combination thereof, or other cells involved in cartilage or bone repair.
7. The scaffold of claim 5 , wherein said growth factor is epidermal growth factor (EGF), transforming growth factor-beta (TGF-β), human endothelial cell growth factor (ECGF), granulocyte macrophage colony stimulating factor (GM-CSF), bone morphogenetic protein (BMP), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), insulin-like growth factor (IGF), cartilage derived morphogenetic protein (CDMP), platelet derived growth factor (PDGF), or a combination thereof.
8. The scaffold of claim 1 , wherein said scaffold approximates the form of a cylinder, cone, screw, rectangular bar, plate, disc, pyramid, granule, ball or cube.
9. The scaffold of claim 1 , wherein the scaffold assumes a shape to approximate a meniscus for a knee or elbow; a joint; an articular surface of a bone, a portion of a rib cage, a hip, a pelvis, an ear, a nose, a ligament, a bronchial tube or an intervertebral disc.
10. The scaffold of claim 1 , wherein said scaffold is cylindrical in shape and has a diameter of about 5-40 mm, and a height of about 5-25 mm.
11. The scaffold of claim 1 , wherein said biocompatible polymer is in the form of a polymer coating, forming a polymer layer associated with a portion of said scaffold.
12. The scaffold of claim 11 , wherein said polymer coating is present at a terminus of said scaffold and said coating has a thickness of between about 0.1-10 mm.
13. The scaffold of claim 11 , wherein said polymer is in the form of a hydrogel.
14. The scaffold of claim 4 , wherein said alpha-hydroxy acids comprise poly-lactic acid, polyglycolic acid, enantioners thereof, co-polymers thereof, polyorthoesters, or combinations thereof.
15. The scaffold of claim 1 , wherein said biocompatible polymer is a glycosaminoglycan.
16. The scaffold of claim 4 , wherein said alginate comprises calcium alginate or cross linked calcium alginate.
17. A method of inducing or enhancing repair, regeneration or enhancement of formation of cartilage, bone or a combination thereof, said method comprising implanting in a subject, a scaffold of claim 1 within a site in need of repair, regeneration or enhancement of formation of cartilage, bone or a combination thereof in said subject.
18. The method of claim 17 , wherein said cartilage defect or disorder comprises a full or partial thickness articular cartilage defect; osteochondral defect; osteoarthritis; osteochondritis dissecans; a joint defect; or a defect resulting from trauma, sports, or repetitive stress.
19. The method of claim 17 , wherein said scaffold is positioned such that said at least a second porous phase is implanted within or proximally to cartilage tissue and said at least a first porous phase is implanted within or proximally to bone tissue.
20. A kit for repair of cartilage or bone comprising the scaffold of claim 1 , and directions for utilizing said scaffold in tissue repair.
21. The kit of claim 20 , which further comprises a tool or tools for optimal insertion of said scaffold.
22. The kit of claim 20 , which further comprises a series of scaffolds of different sizes or shapes.
23. The kit of claim 20 , which further comprises a tool or tools for optimal insertion of said scaffold, and a series of scaffolds of different sizes or shapes.